Dimensional Fund Advisors LP Purchases 181,828 Shares of Perrigo Company plc $PRGO

Dimensional Fund Advisors LP raised its position in Perrigo Company plc (NYSE:PRGO) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,695,238 shares of the company’s stock after buying an additional 181,828 shares during the period. Dimensional Fund Advisors LP owned 5.59% of Perrigo worth $171,367,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Cooke & Bieler LP raised its position in Perrigo by 11.6% in the 3rd quarter. Cooke & Bieler LP now owns 3,680,411 shares of the company’s stock valued at $81,963,000 after purchasing an additional 381,290 shares during the last quarter. Bahl & Gaynor Inc. grew its holdings in shares of Perrigo by 5.4% during the third quarter. Bahl & Gaynor Inc. now owns 2,087,075 shares of the company’s stock worth $46,479,000 after purchasing an additional 107,774 shares during the last quarter. Diamond Hill Capital Management Inc. increased its stake in shares of Perrigo by 8.6% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,797,746 shares of the company’s stock valued at $40,036,000 after buying an additional 142,363 shares in the last quarter. Nicola Wealth Management LTD. increased its stake in shares of Perrigo by 38.4% in the third quarter. Nicola Wealth Management LTD. now owns 281,000 shares of the company’s stock valued at $6,257,000 after buying an additional 78,000 shares in the last quarter. Finally, Sound Income Strategies LLC raised its holdings in shares of Perrigo by 35.7% in the third quarter. Sound Income Strategies LLC now owns 717,731 shares of the company’s stock valued at $15,467,000 after buying an additional 188,767 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Price Performance

Shares of PRGO stock opened at $10.33 on Tuesday. The firm’s 50 day moving average price is $14.11 and its two-hundred day moving average price is $16.90. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.63 and a current ratio of 2.76. Perrigo Company plc has a 52-week low of $9.91 and a 52-week high of $29.08. The stock has a market cap of $1.42 billion, a PE ratio of -1.01, a PEG ratio of 1.29 and a beta of 0.41.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, February 26th. The company reported $0.77 EPS for the quarter, missing the consensus estimate of $0.80 by ($0.03). Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the previous year, the firm posted $0.93 EPS. The business’s revenue was down 2.5% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts forecast that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Monday, March 2nd will be paid a $0.29 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $1.16 annualized dividend and a yield of 11.2%. Perrigo’s dividend payout ratio is presently -11.28%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on PRGO. Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a report on Thursday, February 26th. Canaccord Genuity Group reduced their target price on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, February 27th. JPMorgan Chase & Co. decreased their price target on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research note on Monday, December 15th. Argus raised shares of Perrigo to a “hold” rating in a report on Wednesday, January 14th. Finally, Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.